Introduction
This study evaluated the efficacy of a dual‐wavelength 532 nm/1064 nm Nd:YAG picosecond‐domain laser with a holographic lens array in treating facial photoaging.
Methods
Thirteen subjects were enrolled with 10 completing the study. Receiving three‐month treatments, subjects underwent full‐face spot treatment of facial lentigines with the 532‐nm non‐fractionated handpiece, followed by two sequential facial passes of the 1064‐nm and the 532‐nm fractionated handpieces. Improvement was measured by treating physician evaluation of pigmentation and rhytids as well as blinded reviewer evaluation of pre‐ and post‐treatment image sets taken 12 weeks after the final treatment. Participants completed treatment surveys to assess satisfaction.
Results
Physician grading on a 5‐point scale revealed an average improvement of 1.6 in pigmentation (p = 0.0042) and 0.9 in rhytids (p = 0.0196). Blinded physicians appropriately selected baseline images in 44 of 50 (88%) image sets (10 subjects; five reviewers). On an 11‐point scale for overall facial photoaging (0 = no change, 1 = 10% improvement, 2 = 20% improvement, etc.) treating physicians scored mean improvement as 3.3 ± 1.83 (95% CI 1.99 to 4.61; range 1–6), while blinded reviewers scored mean improvement as 2.32 ± 2.62 (range % −4 to 8, 95% CI 1.57 to 3.07). The greatest majority (80%) of participants reported satisfaction with the treatment. Adverse events were mild; however, one patient developed hyperpigmentation, consistent with melasma that was successfully treated with topical agents.
Conclusion
This is the first study to show that picosecond‐domain 532 nm/1064 nm laser treatments with combination non‐fractionated and fractionated handpieces are well‐tolerated, safe, and effective for the treatment of photodamage.
BACKGROUND
The rate of growth for male cosmetic treatments has slowed in the past 5 years. There is limited data on why men may not seek cosmetic treatments.
OBJECTIVE
To evaluate women's perspectives on male cosmetic treatments.
METHODS
Heterosexual female patients (single (n = 64); in a relationship/married (IR/M) (n = 136)) completed an online survey.
RESULTS
87.5% of single and 36.03% of IR/M women reported that men are bothered by signs of aging (p < .0001). However, both single and IR/M women reported that men are interested in (single: 77.78%, IR/M: 65.44%) and will benefit (single: 93.55%, IR/M: 67.31%) from cosmetic procedures. Both groups of women (single: 93.75%, IR/M: 83.82%, p < .0530) indicated, however, that men are reluctant to seek cosmetic treatments. Societal stigma/perception of masculinity was the number one cited reason (single: 87.1.75%, IR/M: 73.02%, p < .0264). However, 87.5% of single and 94.86% of IR/M women (p = .0659) reported that male cosmetic treatments will not affect their perceptions of masculinity. Furthermore, 95% of women (single: 95.31%, IR/M: 95.59%, p = .9292) reported that they will support their partners from pursuing cosmetic treatments.
CONCLUSION
Women strongly believe that men can benefit from cosmetic treatments, do not believe cosmetic treatments affect masculinity, and are overwhelmingly supportive of male cosmetic treatments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.